BioSpace News Archive

Robert Hill brings expertise in the technical and clinical development of radiation systems to speed platform research and commercialization.

Rational Surgical Solutions is pleased to announce that it is the first company in the healthcare information technology space to offer a Blockchain process for confirmation of informed consent for surgical or medical interventions.

Welltok announced that it will present at the annual J.P. Morgan Healthcare Conference on Tuesday, January 8, 8:00 am PT at the San Francisco Westin St. Francis Hotel in Elizabethan C.

A recent nutrition study published in Nutrients revealed heart health benefits for adults who consumed fresh avocado at breakfast

Vitamin Shoppe, Inc. (NYSE: VSI) an omni-channel, specialty retailer of nutritional products, today announced that Andrew Laudato has joined The Vitamin Shoppe as Executive Vice President, Chief Technology Officer effective immediately

CANbridge Pharmaceuticals Inc., a biopharmaceutical company developing innovative drug candidates to treat underserved medical conditions in China and other markets, announced that James Xue, Ph.D., Founder, Chairman and CEO, will present at the 37th Annual J.P. Morgan Healthcare Conference in San Francisco on Wednesday, January 9, 2019 at 10:30 AM Pacific Time.

SOC Telemed (SOC), the leader in acute care telemedicine, is proud to announce it has earned ClearHealth Quality InstituteTM (CHQI) accreditation for telemedicine. CHQI is an independent health care accrediting body that offers the only telemedicine or telehealth accreditation program backed by the American Telemedicine Association (ATA

PrimeVax Immuno-Oncology, Inc. announced today that the company has successfully received their Investigational New Drug (IND) Application permission from the FDA to begin running their first human clinical trial

DiscGenics, Inc. announced that IDCT has passed the initial planned safety review of its Phase I/II trial evaluating the allogeneic, injectable disc cell therapy in patients with mild to moderate degenerative disc disease

The Greater Cannabis Company, Inc. (OTC: GCAN) (“the Company”), a biopharmaceutical company focused on development and commercialization of innovative delivery systems for the Cannabis market is pleased to announce that it has entered into a letter of intent with iCAN Cannabis to expand distribution of its eluting patch platform into key global markets.